tiprankstipranks
Caribou Biosciences (CRBU)
NASDAQ:CRBU
US Market
CRBU
Caribou Biosciences
RESEARCH TOOLSreports

Caribou Biosciences (CRBU) Financial Statements

Compare
923 Followers

Caribou Biosciences Financial Overview

Caribou Biosciences's market cap is currently $172.01M. The company's EPS TTM is $-0.28; its P/E ratio is -1.42; Caribou Biosciences is scheduled to report earnings on March 5, 2026, and the estimated EPS forecast is $-0.31. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 11.16M$ 9.99M$ 34.48M$ 13.85M$ 9.60M
Gross Profit$ 7.51M$ 6.07M$ 30.95M$ 10.21M$ 8.61M
Operating Income$ -136.19M$ -166.62M$ -116.06M$ -106.40M$ -66.98M
EBITDA$ -132.55M$ -162.69M$ -112.53M$ -95.71M$ -65.61M
Net Income$ -148.13M$ -149.10M$ -102.07M$ -99.42M$ -66.92M
Balance Sheet
Cash & Short-Term Investments$ 139.34M$ 209.54M$ 328.83M$ 247.66M$ 375.83M
Total Assets$ 175.37M$ 313.31M$ 432.21M$ 373.76M$ 442.36M
Total Debt$ 27.23M$ 26.49M$ 27.11M$ 27.75M$ 259.00K
Net Debt$ 14.87M$ 10.19M$ -24.05M$ -30.59M$ -240.42M
Total Liabilities$ 53.19M$ 60.36M$ 63.81M$ 72.89M$ 54.53M
Stockholders' Equity$ 122.17M$ 252.95M$ 368.40M$ 300.87M$ 387.82M
Cash Flow
Free Cash Flow$ -112.35M$ -144.71M$ -104.90M$ -97.42M$ -35.64M
Operating Cash Flow$ -110.99M$ -138.20M$ -93.29M$ -90.97M$ -32.52M
Investing Cash Flow$ 102.24M$ 86.61M$ -68.18M$ -93.25M$ -176.40M
Financing Cash Flow$ 4.82M$ 16.72M$ 154.30M$ 2.13M$ 433.43M
Currency in USD

Caribou Biosciences Earnings and Revenue History

Income Statement >

Caribou Biosciences Debt to Assets

Balance Sheet >

Caribou Biosciences Cash Flow

Cash Flow >

Caribou Biosciences Forecast EPS vs Actual EPS

Earnings >